Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.14 is 59% below its 5-year average of 24.85, near the low end of its 5-year range (10.14–115.95).
As of the fiscal period ended Tuesday, June 30, 2026. 26.28% below its 12-month average of 13.76.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.14.
QUICK RATIO (ACID-TEST)
10.14
QUICK RATIO (ACID-TEST) AVG TTM
13.76
QUICK RATIO (ACID-TEST) AVG 3Y
17.04
QUICK RATIO (ACID-TEST) AVG 5Y
24.85
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.28%
CURRENT VS 3Y AVG
-40.47%
CURRENT VS 5Y AVG
-59.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.26
median of 790 covered companies
CURRENT VS SECTOR MEDIAN
+210.66%
vs the sector median at left
Nautilus Biotechnolgy, Inc.
Market Cap
$240.26M
Quick Ratio (Acid-Test)
10.14
TTM Avg
13.76
3Y Avg
17.04
5Y Avg
24.85
Market Cap
$238.90M
Quick Ratio (Acid-Test)
5.86
TTM Avg
4.06
3Y Avg
6.91
5Y Avg
7.76
Market Cap
$242.02M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$238.48M
Quick Ratio (Acid-Test)
16.48
TTM Avg
8.13
3Y Avg
6.57
5Y Avg
7.38
Market Cap
$242.23M
Quick Ratio (Acid-Test)
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.59
Market Cap
$242.27M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$242.31M
Quick Ratio (Acid-Test)
2.69
TTM Avg
2.01
3Y Avg
1.61
5Y Avg
1.29
Market Cap
$236.81M
Quick Ratio (Acid-Test)
0.81
TTM Avg
0.81
3Y Avg
0.76
5Y Avg
0.71
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $240.26M | 10.14 | 13.76 | 17.04 | 24.85 |
| Invivyd, Inc. (IVVD)vs › | $238.90M | 5.86 | 4.06 | 6.91 | 7.76 |
| Galectin Therapeutics Inc. (GALT)vs › | $242.02M | 0.10 | 1.46 | 1.56 | 2.73 |
| SIGA Technologies, Inc. (SIGA)vs › | $238.48M | 16.48 | 8.13 | 6.57 | 7.38 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.23M | 4.70 | 7.13 | 7.51 | 5.59 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.27M | 1.54 | 1.17 | 19.33 | 29.22 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | 2.69 | 2.01 | 1.61 | 1.29 |
| InflaRx N.V. (IFRX)vs › | $237.14M | 8.22 | 4.35 | 5.50 | 5.94 |
| High Tide Inc. (HITI)vs › | $236.81M | 0.81 | 0.81 | 0.76 | 0.71 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.60M | 1.35 | 1.13 | 1.14 | 1.18 |
Quick Ratio
10.14
Excludes inventory
Current Ratio
10.14
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.14 |
| 2026-03-31 | 11.85 |
| 2025-12-31 | 13.33 |
| 2025-09-30 | 14.95 |
| 2025-06-30 | 18.52 |
| 2025-03-31 | 17.36 |
| 2024-12-31 | 17.40 |
| 2024-09-30 | 16.65 |
| 2024-06-30 | 19.69 |
| 2024-03-31 | 20.09 |
| 2023-12-31 | 19.39 |
| 2023-09-30 | 21.00 |
| 2023-06-30 | 21.13 |
| 2023-03-31 | 21.50 |
| 2022-12-31 | 27.57 |
| 2022-09-30 | 40.60 |
| 2022-06-30 | 49.75 |
| 2022-03-31 | 51.06 |
| 2021-12-31 | 60.09 |
| 2021-09-30 | 83.68 |
| 2021-06-30 | 115.95 |
| 2021-03-31 | 15.35 |
| 2020-12-31 | 25.73 |
| 2020-09-30 | 11.15 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 34.62 |
| 2019-09-30 | 7.64 |
| 2019-06-30 | 25.45 |
| 2019-03-31 | 23.14 |
| 2018-12-31 | 266.45 |
